Skip to main content

Table 3 Intra– and postoperative outcomes of matched cohort with and without a prolonged length of stay

From: Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study

  LOS ≤ 14 Days LOS > 14 Days
Pyridostigmine (n = 83) Sugammadex (n = 93) p value Pyridostigmine (n = 44) Sugammadex (n = 34) p value
Surgery time (min) 210.0 (180.0–240.0) 205.0 (175.0–240.0) 0.230 240.0 (210.0–270.0) 235.0 (185.0–255.0) 0.457
PCA
 Epidural 72 (86.7) 62 (66.7) 0.003 38 (86.4) 28 (82.4) 0.865
 Intravenous 11 (13.3) 31 (33.3)   6 (13.6) 6 (17.6)  
LOS (days) 10.0 (9.0–12.0) 9.0 (7.0–10.0) 0.002 19.0 (16.0–26.0) 19.0 (16.0–23.0) 0.537
PACU stay (min) 60.0 (55.0–75.0) 60.0 (55.0–75.0) 0.611 70.0 (60.0–90.0) 60.0 (55.0–75.0) 0.007
Events in PACU
 Dyspnea 1 (1.2) 2 (2.2) 1.000 3 (6.8) 1 (2.9) 0.801
 HDI 4 (4.8) 3 (3.2) 0.878 3 (6.8) 1 (2.9) 0.801
Events in ward
 Pyrexia 21 (25.3) 16 (17.2) 0.258 17 (38.6) 12 (35.3) 0.947
 Dyspnea 5 (6.0) 4 (4.3) 0.861 12 (27.3) 6 (17.6) 0.466
 Air leak > 5 days 3 (3.6) 6 (6.5) 0.610 24 (54.5) 19 (55.9) 1.000
 Atelectasis 21 (25.3) 11 (11.8) 0.034 17 (38.6) 12 (35.3) 0.947
 Pneumonia 0 (0.0) 1 (1.1) 1.000 9 (20.5) 5 (14.7) 0.720
 MV 1 (1.2) 0 (0.0) 0.954 2 (4.5) 2 (5.9) 1.000
 HDI 3 (3.6) 0 (0.0) 0.206 4 (9.1) 1 (2.9) 0.526
 ICU 1 (1.2) 0 (0.0) 0.954 4 (9.1) 2 (5.9) 0.921
  1. Data are presented as n (%) or median (interquartile range)
  2. PCA Patient controlled analgesia, LOS Length of stay, PACU Post anesthesia care unit, MV Mechanical ventilator use, HDI Hemodynamic instability, ICU Intensive care unit admission